cis-platinum and ovarian carcinoma. In vitro chemosensitivity of cultured tumour cells from patients receiving high dose cis-platinum as first line treatment.

Br J Cancer · 1987 · PMC2002397 · PMID 3435704

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In the untreated group other drugs which showed a trend towards cross- sensitivity and cross-resistance with CIS were BLM at I lgml -1 (6/13 vs. 2/13) and 5-FU at 1 gml-1 (8/14 vs. 2/10).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.